Presentation is loading. Please wait.

Presentation is loading. Please wait.

Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial Sanne M Dorhout Mees, MD, Ale Algra, MD, W Peter Vandertop,

Similar presentations


Presentation on theme: "Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial Sanne M Dorhout Mees, MD, Ale Algra, MD, W Peter Vandertop,"— Presentation transcript:

1 Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial Sanne M Dorhout Mees, MD, Ale Algra, MD, W Peter Vandertop, MD, Fop van Kooten, MD, Hans AJM Kuijsten, MD, Jelis Boiten, MD, Robert J van Oostenbrugge, MD, Rustam Al-Shahi Salman, PhD, Pablo M Lavados, MD, Gabriel JE Rinkel, MD, Walter M van den Bergh, MD and on behalf of the MASH-2 study group The Lancet Volume 380, Issue 9836, Pages 44-49Volume 380, Issue 9836, Pages (July 2012) DOI: /S (12) Copyright © 2012 Elsevier Ltd Terms and ConditionsTerms and Conditions

2 Figure 1 Source: The Lancet 2012; 380:44-49 (DOI: /S (12) )The Lancet 2012; 380:44-49 Terms and Conditions

3 Figure 2 Source: The Lancet 2012; 380:44-49 (DOI: /S (12) )The Lancet 2012; 380:44-49 Terms and Conditions

4 Figure 3 Source: The Lancet 2012; 380:44-49 (DOI: /S (12) )The Lancet 2012; 380:44-49 Terms and Conditions

5 Figure 4 Source: The Lancet 2012; 380:44-49 (DOI: /S (12) )The Lancet 2012; 380:44-49 Terms and Conditions


Download ppt "Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial Sanne M Dorhout Mees, MD, Ale Algra, MD, W Peter Vandertop,"

Similar presentations


Ads by Google